Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,307 | 232 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $808.02 | 65 | $0 (2020) |
| Lilly USA, LLC | $382.02 | 26 | $0 (2021) |
| GlaxoSmithKline, LLC. | $327.32 | 25 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $265.69 | 17 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $184.34 | 14 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $147.22 | 10 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $122.28 | 9 | $0 (2018) |
| Medtronic, Inc. | $103.93 | 1 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $96.56 | 7 | $0 (2019) |
| Novo Nordisk Inc | $91.67 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $15.31 | 1 | ABBVIE INC. ($15.31) |
| 2022 | $132.48 | 3 | Medtronic, Inc. ($103.93) |
| 2021 | $121.18 | 9 | GlaxoSmithKline, LLC. ($40.90) |
| 2020 | $297.32 | 20 | Lilly USA, LLC ($56.00) |
| 2019 | $920.42 | 64 | PFIZER INC. ($275.26) |
| 2018 | $1,117 | 83 | PFIZER INC. ($375.29) |
| 2017 | $702.88 | 52 | PFIZER INC. ($126.24) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2022 | Medtronic, Inc. | ENDURANT IIS (Device) | Food and Beverage | In-kind items and services | $103.93 | General |
| Category: Aortic Stent Grafts | ||||||
| 04/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: VACCINES | ||||||
| 07/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: VACCINES | ||||||
| 06/14/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: DIABETES | ||||||
| 04/27/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: VACCINES | ||||||
| 04/01/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, JANUMET | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: DIABETES | ||||||
| 01/19/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Diabetes | ||||||
| 01/12/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: DIABETES | ||||||
| 11/10/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Virology & Specialty Care | ||||||
| 11/05/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: DIABETES | ||||||
| 09/01/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Diabetes | ||||||
| 08/04/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diabetes | ||||||
| 07/28/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/11/2020 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: ADHD | ||||||
| 03/08/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiovascular | ||||||
| 03/04/2020 | Medtronic MiniMed, Inc. | Guardian Connect (Device) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 03/03/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Diabetes | ||||||
| 02/24/2020 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 02/24/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Neuroscience | ||||||
| 02/13/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 397 | 468 | $40,958 | $15,612 |
| 2022 | 12 | 537 | 749 | $49,015 | $15,435 |
| 2021 | 14 | 523 | 716 | $47,972 | $16,638 |
| 2020 | 12 | 669 | 889 | $60,381 | $19,550 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 88 | $14,256 | $6,152 | 43.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $7,406 | $3,956 | 53.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $4,352 | $2,128 | 48.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 66 | 86 | $1,376 | $722.40 | 52.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 48 | 51 | $4,182 | $669.12 | 16.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 56 | 64 | $2,624 | $530.56 | 20.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $434.00 | $419.16 | 96.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 47 | 54 | $1,944 | $410.94 | 21.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 27 | 29 | $1,798 | $276.08 | 15.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 13 | 15 | $930.00 | $155.25 | 16.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 17 | 18 | $1,152 | $101.88 | 8.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 17 | 18 | $504.00 | $91.44 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 135 | $21,870 | $9,276 | 42.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 20 | $1,380 | $1,350 | 97.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 73 | 89 | $7,298 | $1,152 | 15.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 75 | 96 | $3,936 | $786.35 | 20.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 21 | $651.00 | $609.17 | 93.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 45 | 63 | $3,906 | $585.25 | 15.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 56 | 73 | $2,628 | $552.20 | 21.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 83 | 138 | $2,208 | $405.90 | 18.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 14 | 21 | $1,302 | $218.59 | 16.8% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 26 | 38 | $2,432 | $205.76 | 8.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 26 | 38 | $1,064 | $184.58 | 17.3% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 17 | 17 | $340.00 | $109.10 | 32.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 141 | $22,786 | $10,111 | 44.4% |
About Dr. John Rice, M.D
Dr. John Rice, M.D is a Internal Medicine healthcare provider based in Hazelwood, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821079492.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Rice, M.D has received a total of $3,307 in payments from pharmaceutical and medical device companies, with $15.31 received in 2023. These payments were reported across 232 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,307).
As a Medicare-enrolled provider, Rice has provided services to 2,126 Medicare beneficiaries, totaling 2,822 services with total Medicare billing of $67,236. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Hazelwood, MO
- Active Since 11/09/2005
- Last Updated 02/08/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1821079492
Products in Payments
- EUCRISA (Drug) $273.74
- TRULICITY (Drug) $245.94
- LYRICA (Drug) $199.95
- ENTRESTO (Drug) $184.34
- PREVNAR - 13 (Biological) $167.88
- CHANTIX (Drug) $151.39
- FARXIGA (Drug) $107.54
- ENDURANT IIS (Device) $103.93
- Livalo (Drug) $96.56
- TOUJEO (Drug) $93.66
- JARDIANCE (Drug) $88.71
- ANORO (Drug) $84.35
- BREO (Drug) $82.72
- Victoza (Drug) $73.47
- ELIQUIS (Drug) $72.74
- PRALUENT (Drug) $66.75
- OMNITROPE (Drug) $64.00
- SOLIQUA (Drug) $62.94
- BASAGLAR (Drug) $57.93
- VRAYLAR (Drug) $57.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hazelwood
Scott Anderson, M.d, M.D
Internal Medicine — Payments: $6,406
Joyce Boehmer, M.d, M.D
Internal Medicine — Payments: $4,777
Susan Adams, M.d, M.D
Internal Medicine — Payments: $4,703
William Beaman, Md, MD
Internal Medicine — Payments: $2,982
Erin Fick, D.o, D.O
Internal Medicine — Payments: $2,111
Marketa Kasalova, M.d, M.D
Internal Medicine — Payments: $2,014